Harvard Medical School - Doctor of Medicine Los Angeles County Harbor-UCLA Medical Center - Fellowship - Endocrinology, Diabetes, and Metabolism (Internal Medicine)
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Endocrinology and Metabolism (Internal Medicine)
Compositions of purified and biologically active ellagitannins are provided by separation from pomegranate husk using a method of extraction and purification using a solid polymeric adsorbent and the uses of the said compounds
Purifications Of Pomegranate Ellagitannins And Their Uses Thereof
US Patent:
7919636, Apr 5, 2011
Filed:
Jun 20, 2008
Appl. No.:
12/143657
Inventors:
Navindra P. Seeram - Los Angeles CA, US David Heber - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07D 493/00, A01K 43/04, A01N 43/42, A01N 43/16
US Classification:
549278, 514292, 514453, 514456, 514 27
Abstract:
Compositions of purified and biologically active ellagitannins are provided by separation from pomegranate husk using a method of extraction and purification using a solid polymeric adsorbent and the uses of the said compounds.
Purifications Of Pomegranate Ellagitannins And Their Uses Thereof
US Patent:
7897791, Mar 1, 2011
Filed:
Dec 24, 2009
Appl. No.:
12/647229
Inventors:
Navindra P. Seeram - Kingston RI, US David Heber - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07D 493/00, A01K 43/04, A01N 43/42, A01N 43/16
US Classification:
549278, 514292, 514453, 514456, 514 27
Abstract:
Compositions of purified and biologically active ellagitannins are provided by separation from pomegranate husk using a method of extraction and purification using a solid polymeric adsorbent and the uses of the said compounds.
Navindra P. Seeram - Kingston RI, US David Heber - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/366
US Classification:
514455
Abstract:
The subject invention is drawn to ellagitannin metabolites (e. g. , urolithin) that find use in treating or preventing a neoplastic disease in a subject.
Navindra P. Seeram - Los Angeles CA, US David Heber - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/366
US Classification:
514455
Abstract:
The subject invention is drawn to ellagitannin metabolites (e. g. , urolithin) that find use in treating or preventing a neoplastic disease in a subject.